搜尋結果
This new weight loss drug ETF bets big on two of the industry's leading players
CNBC· 16 小時前A top exchange-traded fund provider is betting on the long-term popularity of GLP-1 weight loss ...
Mounjaro And Zepbound Shortages Targeted With $5.3 Billion Eli Lilly Investment
Forbes· 4 日前... $5.3 billion into a new manufacturing site, boosting production for its weight ... ...
Ozempic doesn't make everyone thin. That opens up an opportunity for some stocks
CNBC· 19 小時前It can mean the difference between qualifying for bariatric surgery or not. Or, in other cases, ...
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
CNBC· 4 日前Eli Lilly on Friday said it is investing another $5.3 billion in a manufacturing plant in ...
How digital health companies are capitalizing on the GLP-1 boom
CNBC· 3 日前Novo Nordisk's blockbuster weight loss drug, which contains the second generation GLP-1 ...
Weight-Loss Upstart Viking Needs a Deal to Vie With Lilly and Novo
Bloomberg· 6 日前Hope for a weight-loss drug that’s better than Ozempic and Wegovy has sent Viking Therapeutics ...
Nvidia and more: Citi names global stocks to play the semiconductor boom
CNBC· 8 小時前The global semiconductor industry is set to experience "groundbreaking changes," Citi ...
European markets set to open mixed as UK's FTSE reopens
CNBC· 2 小時前s FTSE 100 was seen opening lower after markets were closed for the late May bank holiday, ...
Lilly Invests $5.3 Billion to Boost Weight-Loss Drug Supply
Bloomberg· 4 日前Have a confidential tip for our reporters? Eli Lilly & Co. will spend $5.3 billion to boost ...
The Top 10 S&P 500 Stocks By Weight—A Boon Or Bane?
Forbes· 6 日前The S&P 500 index closed Tuesday’s trade at 5,321.41, setting a new all-time high, above the ...
weight 相關
廣告